AI Verdict
LGNZZ has stronger fundamentals based on our AI analysis.
LGNZZ vs LGCY Fundamental Comparison
| Metric | LGNZZ | LGCY |
|---|---|---|
| Revenue | $268.1M | $38.6M |
| Net Income | $124.5M | $4.2M |
| Net Margin | 46.4% | 11.0% |
| ROE | 12.2% | 9.2% |
| ROA | 8.0% | 5.8% |
| Current Ratio | 22.23x | 2.98x |
| Debt/Equity | 0.03x | 0.01x |
| EPS | $6.13 | $0.30 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LGNZZ vs LGCY: Frequently Asked Questions
Is LGNZZ or LGCY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LGNZZ has stronger fundamentals. LGNZZ is rated BUY (75% confidence) while LGCY is rated BUY (70% confidence). This is not investment advice.
How does LGNZZ compare to LGCY fundamentally?
LIGAND PHARMACEUTICALS INC has ROE of 12.2% vs Legacy Education Inc.'s 9.2%. Net margins are 46.4% vs 11.0% respectively.
Which stock pays higher dividends, LGNZZ or LGCY?
LGNZZ has a dividend yield of N/A or no dividend while LGCY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LGNZZ or LGCY for long term?
For long-term investing, consider that LGNZZ has BUY rating with 75% confidence, while LGCY has BUY rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LGNZZ vs LGCY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LGNZZ vs LGCY, the AI consensus favors LGNZZ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.